These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9665610)

  • 1. Effects of adrenalectomy on hyperphagia induced by the 5-HT1A receptor agonist 8-OH-DPAT and 2-deoxy-D-glucose in rats.
    Yamada J; Sugimoto Y; Yoshikawa T
    Neuroreport; 1998 Jun; 9(8):1831-3. PubMed ID: 9665610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y; Kimura I; Watanabe Y; Yamada J
    Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a nitric oxide synthase inhibitor on 5-HT1A receptor agonist 8-OH-DPAT-induced hyperphagia in rats.
    Yamada J; Sugimoto Y; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1996 Nov; 316(1):23-6. PubMed ID: 8982645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A; Li Q; Battaglia G; Van de Kar LD
    Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of nitric oxide in the 5-HT1A autoreceptor-mediated hyperphagia in rats.
    Sugimoto Y; Yoshikawa T; Yamada J
    Adv Exp Med Biol; 1999; 467():109-11. PubMed ID: 10721047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of interaction between devazepide and 8-OH-DPAT-induced hyperphagia in the rat.
    Francis J; Dourish CT; Cooper SJ
    Physiol Behav; 1996 Nov; 60(5):1337-40. PubMed ID: 8916191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of adrenalectomy and ovariectomy on the behavioral and hypothermic responses of rats to 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT).
    Young AH; Dow RC; Goodwin GM; Fink G
    Neuropharmacology; 1993 Jul; 32(7):653-7. PubMed ID: 8361580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-OH-DPAT stimulates gastric acid secretion through a vagal-independent, adrenal-mediated mechanism.
    Gidener S; LePard KJ; Stephens RL
    Eur J Pharmacol; 1995 Sep; 284(1-2):19-24. PubMed ID: 8549624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of peripheral 5-HT2 and 5-HT3 receptor agonists on food intake in food-deprived and 2-deoxy-D-glucose-treated rats.
    Sugimoto Y; Yamada J; Yoshikawa T; Noma T; Horisaka K
    Eur J Pharmacol; 1996 Nov; 316(1):15-21. PubMed ID: 8982644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of WAY-100135 and 8-hydroxy-2-(di-n-propylamino)tetralin on feeding in the rat.
    Hartley JE; Fletcher A
    Eur J Pharmacol; 1994 Feb; 252(3):329-32. PubMed ID: 8162954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated 2-deoxy-D-glucose administration on ingestive, psychological, and 5-HT-related behaviours in the rat.
    Chaouloff F
    Neuropharmacology; 1994 May; 33(5):693-703. PubMed ID: 7936105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity to 8-hydroxy-2-(di-n-propylamino)tetralin-induced corticosterone secretion and hypothermia between Sprague-Dawley rats from different breeding colonies.
    Kelder D; Ross SB
    Pharmacol Toxicol; 2001 Dec; 89(6):295-300. PubMed ID: 11903954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nitric oxide synthase inhibitor reduces hyperphagia induced in rats by the 5-HT(1A) receptor agonist, 8-OH-DPAT, independently of hypothalamic serotonin metabolism.
    Yamada J; Sugimoto Y; Kunitomo M
    Eur J Pharmacol; 2000 Aug; 402(3):247-50. PubMed ID: 10958891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress.
    Saphier D; Welch JE
    J Neurochem; 1995 Feb; 64(2):767-76. PubMed ID: 7530293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice.
    Man MS; Young AH; McAllister-Williams RH
    J Psychopharmacol; 2002 Sep; 16(3):245-52. PubMed ID: 12236633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated corticosterone treatment attenuates behavioural and neuroendocrine responses to 8-hydroxy-2-(di-n-propylamino) tetralin in rats.
    Haleem DJ
    Life Sci; 1992; 51(23):PL225-30. PubMed ID: 1435084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 5-HT1A receptors in the proliferation and survival of progenitor cells in the dentate gyrus of the adult hippocampus and their regulation by corticoids.
    Huang GJ; Herbert J
    Neuroscience; 2005; 135(3):803-13. PubMed ID: 16129565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neuronal nitric oxide synthase inhibitor 7-nitroindazole reduces the 5-HT1A receptor against 8-OH-DPAT-elicited hyperphagia in rats.
    Sugimoto Y; Yamada J; Yoshikawa T
    Eur J Pharmacol; 1999 Jul; 376(1-2):1-5. PubMed ID: 10440082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia.
    Kline AE; Massucci JL; Dixon CE; Zafonte RD; Bolinger BD
    J Neurotrauma; 2004 Feb; 21(2):175-85. PubMed ID: 15000758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.